Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.06B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.87B |
| 3 |
Apple
AAPL
|
+$1.03B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$747M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$730M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$930M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$598M |
| 3 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$524M |
| 4 |
TSMC
TSM
|
+$363M |
| 5 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.47% |
| 2 | Healthcare | 9.44% |
| 3 | Financials | 9.02% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5376
ProFrac Holding
ACDC
$807M
| $197K | ﹤0.01% |
+12,924
| New | +$233K |
|
|
FCT
5377
First Trust Senior Floating Rate Income Fund II
FCT
$251M
| $197K | ﹤0.01% |
19,676
-700
| -3% | -$7.14K |
|
5378
Star Group
SGU
$419M
| $197K | ﹤0.01% |
24,265
-3,138
| -11% | -$29.4K |
|
|
FRW
5379
DELISTED
PWP Forward Acquisition Corp. I Class A Common Stock
FRW
| $197K | ﹤0.01% |
20,108
-213,100
| -91% | -$2.09M |
|
|
CTLP
5380
DELISTED
Cantaloupe
CTLP
| $196K | ﹤0.01% |
56,376
+1,609
| +3% | +$8.83K |
|
5381
UroGen Pharma
URGN
$2.22B
| $196K | ﹤0.01% |
23,592
-14,643
| -38% | -$121K |
|
5382
Larimar Therapeutics
LRMR
$436M
| $195K | ﹤0.01% |
+60,930
| New | +$153K |
|
|
OPRA
5383
Opera Ltd
OPRA
$1.75B
| $195K | ﹤0.01% |
44,919
-200,871
| -82% | -$964K |
|
5384
Vita Coco
COCO
$3.71B
| $194K | ﹤0.01% |
+17,075
| New | +$223K |
|
5385
CytomX Therapeutics
CTMX
$734M
| $194K | ﹤0.01% |
133,693
-53,849
| -29% | -$82.9K |
|
5386
SmartRent
SMRT
$264M
| $194K | ﹤0.01% |
85,212
+49,192
| +137% | +$194K |
|
|
PKBO
5387
DELISTED
Peak Bio, Inc. Common Stock
PKBO
| $194K | ﹤0.01% |
19,428
-8,000
| -29% | -$79.4K |
|
|
AKUS
5388
DELISTED
Akouos Inc
AKUS
| $194K | ﹤0.01% |
28,722
+3,817
| +15% | +$14.3K |
|
|
DRD
5389
DRDGold
DRD
$1.95B
| $193K | ﹤0.01% |
+35,307
| New | +$203K |
|
|
PBT
5390
Permian Basin Royalty Trust
PBT
$1.47B
| $193K | ﹤0.01% |
+11,830
| New | +$206K |
|
5391
Xeris Biopharma Holdings
XERS
$1.27B
| $191K | ﹤0.01% |
122,646
+10,106
| +9% | +$16.7K |
|
5392
Janux Therapeutics
JANX
$982M
| $190K | ﹤0.01% |
14,047
-1,817
| -11% | -$24.3K |
|
5393
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$901M
| $190K | ﹤0.01% |
19,336
| – | – |
|
5394
FT Vest Growth-100 Buffer ETF March
QMAR
$575M
| $190K | ﹤0.01% |
+10,105
| New | +$205K |
|
|
SOHU
5395
Sohu.com
SOHU
$368M
| $190K | ﹤0.01% |
11,814
-7,573
| -39% | -$128K |
|
5396
CALL
XP
XP
$8.62B
| $190K | ﹤0.01% |
10,000
-2,990,000
| -100% | -$59.3M |
|
5397
Biomea Fusion
BMEA
$90.4M
| $189K | ﹤0.01% |
19,355
+1,119
| +6% | +$12.8K |
|
|
NEXN
5398
Nexxen International
NEXN
$610M
| $189K | ﹤0.01% |
27,320
-2,685
| -9% | -$23.6K |
|
5399
Mistras Group
MG
$498M
| $188K | ﹤0.01% |
42,119
+3,717
| +10% | +$21.1K |
|
|
FTCH
5400
PUT
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $186K | ﹤0.01% |
+25,000
| New | +$222K |
|
Similar funds
Goldman Sachs's Q3 2022 Portfolio in Review
As of Q3 2022, Goldman Sachs held 6,885 positions worth $396B, down 1.1% from $400B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs deployed $17.3B of net new capital in Q3 2022, opening 459 new positions and adding to 2,707 existing holdings. Its largest new stake was Schwab US TIPS ETF: 8,348,958 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $930M trimmed.
- Goldman Sachs's largest Q3 2022 buy was Schwab US TIPS ETF: 8,348,958 shares worth $216M.
- Goldman Sachs added most to Visa in Q3 2022, an estimated $2.06B increase.
- Goldman Sachs's biggest Q3 2022 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $930M.
- Goldman Sachs fully exited Mandiant, Inc. Common Stock in Q3 2022, selling an estimated $236M.
- Goldman Sachs's ten largest holdings make up 18% of its $396B portfolio in Q3 2022.
- Goldman Sachs opened 459 new positions and closed 646 in Q3 2022.
- Goldman Sachs's portfolio value fell 1.1% quarter-over-quarter to $396B.
Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.